RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of March 9, 2005, between Avicena Group, Inc., a Delaware corporation (the “Company”), and Belinda Tsao Nivaggioli (“Employee”).
RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of February 9, 2005, between Avicena Group, Inc., a Delaware corporation (the “Company”), and Leslie Fang (“Recipient”).
Avicena Group, Inc. Subscription AgreementSubscription Agreement • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products • Delaware
AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products • Delaware
This Amendment No. 1 to Agreement and Plan of Merger (this “Amendment”) is made and entered into this 29th day of July, 2005, by and between Avicena Group., Inc., a Delaware corporation (“Avicena”), and AVN Acquisition Corp., a Delaware corporation (“AVN”).
Subscription Agreement for Placement of Avicena Group, Inc. UnitsSubscription Agreement • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products
By its execution and delivery of this subscription agreement, the undersigned Subscriber hereby joins in and agrees to purchase the aggregate number of Units set forth below:
NOTELoan Agreement • August 10th, 2005 • Avicena Group, Inc. • Medicinal chemicals & botanical products
FOR VALUE RECEIVED, the undersigned, AVN ACQUISITION CORP., having an address of 497 Delaware Avenue, Buffalo, New York 14202 (the “Borrower”), hereby promises to pay to the order of Karen Georgiou, having an address of 10150 Pineview Trail Campbellville, Ontario, L0P 1B0 (the “Lender”), the principal sum of Two Hundred Fifty Thousand Dollars ($250,000) (All monetary amounts herein are expressed in U.S. Dollars). Principal on this Note shall be payable on May 31, 2006 or such earlier date as (i) the Borrower shall complete its proposed merger with Avicena Group, Inc. (“Avicena”) or (ii) Avicena shall have repaid a certain loan of even date herewith made by Borrower to Avicena. Interest on the outstanding principal amount shall accrue at the rate of eight percent (8%) per annum, payable on December 31 for so long as this Note shall remain outstanding and at Maturity.
